Clinical Trial Update: The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mini-dose glucagon to prevent exercise-induced hypoglycemia in adults with Type 1 diabetes; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• mini-dose glucagon (glucagon (mini-dose formulation))

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2018-08-07